The largest community of pharma leaders

Eureka 93 Inc. Engages Peter Ostapchuk as Senior Financial Advisor

TORONTO–()–Please replace the release issued October 28, 2019 with the following corrected version due to multiple revisions.

The corrected release reads:


Eureka 93 Inc. (CSE: ERKA, “Eureka93”) announced today that the company has engaged Peter Ostapchuk as Senior Financial Advisor, effective October 29, 2019.

“With experience in financial reporting and related disclosures, restructuring and creating shareholder value, Mr. Ostapchuk has the breadth of knowledge to support our drive for renewed transformation” said Seann Poli and Owen Kenney, Co-Chief Executive Officers of Eureka93. “Mr. Ostapchuk also brings experience in corporate governance, business strategy, public company regulatory disclosures, mergers and acquisitions, and enterprise risk management.”

Mr. Ostapchuk is a graduate of McMaster University, a Chartered Professional Accountant (CPA-Chartered Accountant), an accredited ICD.D director through the Institute of Corporate Directors, Audit Committee Certified (ACC) with the Directors College of Canada, and designated as a Certified Information Technology Professional (CITP).

“Mr. Ostapchuk’s involvement as Senior Financial Advisor will lead to better outcomes for organization-wide performance improvements. His initial priority will be to complete and file second and third quarter financial statements, management, discussion and analysis (“MD&A”), and certifications as at June 30, 2019 and September 30, 2019 respectively, to help the company remove the Cease Trade Order (“CTO”) issued by the Ontario Securities Commission on September 5, 2019” said Seann Poli.

About Eureka93

Eureka 93 Inc. (Eureka93) is a vertically integrated life sciences company focused on the cultivation, extraction, and distribution of cannabis and hemp-derived cannabidiol (CBD) through it’s Health Canada licensed Artiva facility in Ottawa, Canada, and of hemp-derived CBD in its Montana, USA, location. This multi-faceted company is dedicated to producing the highest-quality products for its customers, including full-plant extract, distillate, and isolate. Leveraging high volume extraction processes, research, and scientific expertise across cannabis and hemp-derived CBD, Eureka93 leads with ingenuity, from the ground up. For more information, please visit:


Recent Articles